HKSE:02659 (China)
Â
Ordinary Shares- Class H
HK$
15.99
+0.090 (+0.57%)
Aug 27
Business Description
Shanghai Bao Pharmaceuticals Co Ltd
ISIN : CNE100007B92
Share Class Description:
HKSE:02659: Ordinary Shares- Class HTotal Employee Number:
354Compare
Compare
Traded in other countries / regions
02659.Hong Kong Index Membership
Hong Kong Stock Connect IPO Date
2025-12-10Description
Shanghai Bao Pharmaceuticals Co Ltd is a biotechnology company with an approved product and a diverse clinical pipeline, leveraging synthetic biology technology to develop and deliver recombinant biologic drugs in China, targeting conditions with limited treatment options and complex manufacturing challenges. The company has proprietary technology platforms, supported by its chassis cell engineering technology, that combine drug design and bioprocessing capabilities. It has production lines for finished dosage forms, including injectable solutions, lyophilized powder injections, and pre-filled syringes. The group has only one reportable operating segment, which is the research, development, and commercialisation of pharmaceutical products.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.22 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | -0.9 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.81 | |||||
Beneish M-Score | 2.73 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 77.05 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 132.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 25.98 | |||||
9-Day RSI | 30.18 | |||||
14-Day RSI | 33.47 | |||||
3-1 Month Momentum % | -30.83 | |||||
6-1 Month Momentum % | -90.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.12 | |||||
Quick Ratio | 4.1 | |||||
Cash Ratio | 4.02 | |||||
Days Inventory | 362.82 | |||||
Days Sales Outstanding | 0.88 | |||||
Days Payable | 0.55 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 88.91 | |||||
Operating Margin % | -746.15 | |||||
Net Margin % | -807.53 | |||||
EBITDA Margin % | -719.43 | |||||
FCF Margin % | -681.35 | |||||
OCF Margin % | -367.34 | |||||
ROE % | -34.36 | |||||
ROA % | -24.04 | |||||
ROIC % | -38.53 | |||||
ROC (Joel Greenblatt) % | -51.73 | |||||
ROCE % | -28.32 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 96.9 | |||||
PB Ratio | 2.96 | |||||
Price-to-Tangible-Book | 2.98 | |||||
EV-to-EBIT | -9.36 | |||||
EV-to-EBITDA | -10.34 | |||||
EV-to-Revenue | 74.42 | |||||
EV-to-FCF | -10.92 | |||||
| Price-to-Net-Current-Asset-Value | 6.4 | |||||
| Price-to-Net-Cash | 6.69 | |||||
Earnings Yield (Greenblatt) % | -10.68 | |||||
FCF Yield % | -7.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Bao Pharmaceuticals Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 53.814 | ||
| EPS (TTM) (HK$) | -1.496 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 33.47 | ||
| 14-Day ATR (HK$) | 0.928849 | ||
| 20-Day SMA (HK$) | 16.8555 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 15.3 - 206 | ||
| Shares Outstanding (Mil) | 324.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Bao Pharmaceuticals Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Bao Pharmaceuticals Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Bao Pharmaceuticals Co Ltd Frequently Asked Questions
What is Shanghai Bao Pharmaceuticals Co Ltd(HKSE:02659)'s stock price today?
The current price of HKSE:02659 is HK$15.99. The 52 week high of HKSE:02659 is HK$206.00 and 52 week low is HK$15.30.
When is next earnings date of Shanghai Bao Pharmaceuticals Co Ltd(HKSE:02659)?
The next earnings date of Shanghai Bao Pharmaceuticals Co Ltd(HKSE:02659) is .
Does Shanghai Bao Pharmaceuticals Co Ltd(HKSE:02659) pay dividends? If so, how much?
Shanghai Bao Pharmaceuticals Co Ltd(HKSE:02659) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Shanghai Bao Pharmaceuticals Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers